Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vitamin E Assay
|
4 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.800 | 1.000 | 1 | 2011 | 2011 | ||||
Serum albumin measurement
|
3282 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
Vitamin K Assay
|
6 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||
Ischemic stroke
|
704 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.060 | 1.000 | 6 | 2008 | 2018 | ||||
Hypertensive disease
|
1085 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2012 | 2019 | ||||
Atrial Fibrillation
|
584 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2018 | 2018 | ||||
Adrenoleukodystrophy
|
116 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Cerebral Infarction
|
123 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Cerebrovascular accident
|
591 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Cerebrovascular Disorders
|
56 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Coronary Artery Disease
|
1577 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Coronary heart disease
|
1178 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Crohn Disease
|
1147 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Drug usage
|
21 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1 | 2012 | 2012 | |||||
Metabolic Syndrome X
|
591 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1 | 2012 | 2012 | |||||
Myocardial Infarction
|
680 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Post transplant diabetes mellitus
|
11 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Primary malignant neoplasm
|
1374 | 0.742 | 0.280 | 19 | 15879621 | missense variant | C/T | snv | 0.27 | 0.22 | 0.010 | 1 | 2012 | 2012 |